Prognostic role of beclin-1 in locally advanced non-small cell lung cancer in patients receiving docetaxel-platinum induction chemotherapy.
Conclusions: Our findings suggest that high beclin-1 expression predicts longer survival in locally advanced NSCLC and docetaxel-platinum IC is a treatment option that deserves consideration.
PMID: 30184615 [PubMed - as supplied by publisher]
Source: The Korean Journal of Internal Medicine - Category: Internal Medicine Authors: Lee HY, Shin JH, Lee KY, Park JK, Sung SW, Kim YS, Kang JH, Kim JO Tags: Korean J Intern Med Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Docetaxel | Gastroschisis Repair | Internal Medicine | Lung Cancer | Non-Small Cell Lung Cancer | Statistics | Study | Taxotere